Search
for
Sort by
Research 121–150 of 189
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Current Biomedical Applications of 3D-Printed Hydrogels
- Pericytes in wound healing: friend or foe?
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Commonalities Between COVID-19 and Radiation Injury
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
- Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
- Non-invasive skin measurement methods and diagnostics for vitiligo: a systematic review
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Biology of hair pigmentation and its role in premature canities
- Exploring the reality of exosomes in dermatology
- Exploring the Therapeutic Potential of TGF-β Inhibitors for Liver Fibrosis: Targeting Multiple Signaling Pathways
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Reductive Stress Selectively Disrupts Collagen Homeostasis and Modifies Growth Factor-independent Signaling Through the MAPK/Akt Pathway in Human Dermal Fibroblasts
- Ruxolitinib found to cause eyelash growth: a case report
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
- Rapid hair depigmentation in patient treated with pazopanib
- Bridging the organoid translational gap: integrating standardization and micropatterning for drug screening in clinical and pharmaceutical medicine
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- An open-access data set of pig skin anatomy and physiology for modelling purposes
- Hair cell toxicology: With the help of a little fish
- COVID-19: The question of genetic diversity and therapeutic intervention approaches